Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Regina Grebla, Juliana Setyawan, Chanhyun Park, Kristin M. Richards, Esmond D. Nwokeji, Manjiri Pawaskar, M. Haim Erder & Kenneth A. Lawson. (2019) Examining the heterogeneity of treatment patterns in attention deficit hyperactivity disorder among children and adolescents in the Texas Medicaid population: modeling suboptimal treatment response. Journal of Medical Economics 22:8, pages 788-797.
Read now
Read now
Timothy Wigal, Matthew Brams, Glen Frick, Brian Yan & Manisha Madhoo. (2018) A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design. Postgraduate Medicine 130:5, pages 481-493.
Read now
Read now
Alain Joseph, Martin Cloutier, Annie Guérin, Roy Nitulescu & Vanja Sikirica. (2016) Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine. Patient Preference and Adherence 10, pages 391-405.
Read now
Read now
Tamás Treuer, Luis Méndez, William Montgomery & Shenghu Wu. (2016) Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review. Neuropsychiatric Disease and Treatment 12, pages 1061-1083.
Read now
Read now
Kavita Gajria, Mei Lu, Vanja Sikirica, Peter Greven, Yichen Zhong, Paige Qin & Jipan Xie. (2014) Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review. Neuropsychiatric Disease and Treatment 10, pages 1543-1569.
Read now
Read now
Carlos Roncero & F Javier Álvarez. (2014) The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders. Expert Review of Neurotherapeutics 14:8, pages 849-865.
Read now
Read now
N. S. Roskell, J. Setyawan, E. A. Zimovetz & P. Hodgkins. (2014) Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine. Current Medical Research and Opinion 30:8, pages 1673-1685.
Read now
Read now
Articles from other publishers (9)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Rebecca Bungay, Annie Guerin & Ann Childress. (2022) Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study. Advances in Therapy 39:12, pages 5487-5503.
Crossref
Crossref
Muhammad Umair Khan & Parisa Aslani. (2020) A review of measures used to examine medication adherence in people with ADHD at initiation, implementation and discontinuation of pharmacotherapy. Research in Social and Administrative Pharmacy 16:3, pages 277-289.
Crossref
Crossref
Geon Ho Bahn, Young Sik Lee, Hanik K. Yoo, Eui-Jung Kim, Subin Park, Doug Hyun Han, Minha Hong, Bongseog Kim, Soyoung Irene Lee, Soo Young Bhang, Seung Yup Lee, Jin Pyo Hong & Yoo-Sook Joung. (2020) Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder. Journal of the Korean Academy of Child and Adolescent Psychiatry 31:1, pages 5-25.
Crossref
Crossref
Joseph BiedermanRonna FriedMaura DiSalvoBarbara StorchAlexa PulliK. Yvonne WoodworthItai BiedermanStephen V. FaraoneRoy H. Perlis. (2019) Evidence of Low Adherence to Stimulant Medication Among Children and Youths With ADHD: An Electronic Health Records Study. Psychiatric Services 70:10, pages 874-880.
Crossref
Crossref
J.J.S. Kooij, D. Bijlenga, L. Salerno, R. Jaeschke, I. Bitter, J. Balázs, J. Thome, G. Dom, S. Kasper, C. Nunes Filipe, S. Stes, P. Mohr, S. Leppämäki, M. Casas, J. Bobes, J.M. Mccarthy, V. Richarte, A. Kjems Philipsen, A. Pehlivanidis, A. Niemela, B. Styr, B. Semerci, B. Bolea-Alamanac, D. Edvinsson, D. Baeyens, D. Wynchank, E. Sobanski, A. Philipsen, F. McNicholas, H. Caci, I. Mihailescu, I. Manor, I. Dobrescu, T. Saito, J. Krause, J. Fayyad, J.A. Ramos-Quiroga, K. Foeken, F. Rad, M. Adamou, M. Ohlmeier, M. Fitzgerald, M. Gill, M. Lensing, N. Motavalli Mukaddes, P. Brudkiewicz, P. Gustafsson, P. Tani, P. Oswald, P.J. Carpentier, P. De Rossi, R. Delorme, S. Markovska Simoska, S. Pallanti, S. Young, S. Bejerot, T. Lehtonen, J. Kustow, U. Müller-Sedgwick, T. Hirvikoski, V. Pironti, Y. Ginsberg, Z. Félegyházy, M.P. Garcia-Portilla & P. Asherson. (2018) Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry 56:1, pages 14-34.
Crossref
Crossref
Peter Greven, Vanja Sikirica, Yaozhu J. Chen, Tammy G. Curtice & Charles Makin. (2016) Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany. The European Journal of Health Economics 18:7, pages 893-904.
Crossref
Crossref
Evelina A. Zimovetz, Stephen M. Beard, Paul Hodgkins, Matthias Bischof, Josephine A. Mauskopf & Juliana Setyawan. (2016) A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate. CNS Drugs 30:10, pages 985-996.
Crossref
Crossref
Allan Hvolby. (2014) Associations of sleep disturbance with ADHD: implications for treatment. ADHD Attention Deficit and Hyperactivity Disorders 7:1, pages 1-18.
Crossref
Crossref
Presenter: Seeba AnamDiscussant: Barbara J. Coffey. (2013) Exacerbation of Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, and Chronic Motor Tics During Treatment of Attention-Deficit/Hyperactivity Disorder: Medication Management in an Older Adolescent. Journal of Child and Adolescent Psychopharmacology 23:8, pages 577-582.
Crossref
Crossref